These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 6334746

  • 21. The type I interferon system in idiopathic inflammatory myopathies.
    Lundberg IE, Helmers SB.
    Autoimmunity; 2010 Apr; 43(3):239-43. PubMed ID: 20187702
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Polymyositis and Jo-1 syndrome].
    Treher E, Niederhoff A, Gellissen U, Schmidt P, Dornberg M, Peter HH.
    Z Rheumatol; 1993 Apr; 52(5):301-6. PubMed ID: 8259722
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Clinical value of myositis antibodies in patients with connective tissue disease-associated interstitial lung diseases].
    Xie MM, Zou RY, Li Y, Liu Y, Chen LL, Liu XQ, Zhao Q, Ding JJ, Chen ZY, Cai HR.
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Oct 12; 42(10):765-770. PubMed ID: 31594111
    [Abstract] [Full Text] [Related]

  • 28. Predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis or dermatomyositis: a retrospective study.
    Ji SY, Zeng FQ, Guo Q, Tan GZ, Tang HF, Luo YJ, Tang ZQ, Han YF.
    Chin Med J (Engl); 2010 Mar 05; 123(5):517-22. PubMed ID: 20367973
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Cyclophosphamide treatment of interstitial pulmonary fibrosis in polymyositis/dermatomyositis.
    al-Janadi M, Smith CD, Karsh J.
    J Rheumatol; 1989 Dec 05; 16(12):1592-6. PubMed ID: 2625692
    [Abstract] [Full Text] [Related]

  • 31. [Antisynthetase syndrome].
    Gran JT.
    Tidsskr Nor Laegeforen; 2002 Sep 30; 122(23):2270-2. PubMed ID: 12448266
    [Abstract] [Full Text] [Related]

  • 32. Clinical features and prognosis of patients with idiopathic inflammatory myopathies and anti-Jo-1 antibodies.
    Mielnik P, Wiesik-Szewczyk E, Olesinska M, Chwalinska-Sadowska H, Zabek J.
    Autoimmunity; 2006 May 30; 39(3):243-7. PubMed ID: 16769658
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [The anti-Jo-1 syndrome - a specific form of myositis with interstitial lung disease].
    Häussermann A, Gillissen A, Seidel W.
    Pneumologie; 2010 Aug 30; 64(8):496-503. PubMed ID: 20387195
    [Abstract] [Full Text] [Related]

  • 37. [Anti-Jo-1 antibodies: specific autoantibodies for polymyositis with interstitial pulmonary fibrosis. 2 case reports].
    Fischer E, Thiele A, Stierle HE, Lang B.
    Z Rheumatol; 1995 Aug 30; 54(3):171-7. PubMed ID: 7660688
    [Abstract] [Full Text] [Related]

  • 38. Interstitial lung disease in dermatomyositis: clinicopathological study.
    Takizawa H, Shiga J, Moroi Y, Miyachi S, Nishiwaki M, Miyamoto T.
    J Rheumatol; 1987 Feb 30; 14(1):102-7. PubMed ID: 3494844
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.